Prescription Drug Costs Are Skyrocketing. Will Medicare Part D Bring Relief? | News Channel 3-12

Prescription drug costs are skyrocketing. Will Medicare Part D bring relief? | News Channel 3-12

Maria Dryfhout // Shutterstock Prescription drug costs are skyrocketing. Will Medicare Part D bring relief? The law of supply and demand dictates that when competition is scarce, prices will inevitably skyrocket. In the health care realm, this often means that patients facing high drug costs are often forced to forgo care, a decision that can lead to health complications. For Medicare beneficiaries in particular, soaring specialty drug prices an…

Prescription drug costs are skyrocketing. Will Medicare Part D bring relief?

CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges remain in drug pricing and access.

How May the IRA Shift Part D Market Dynamics?

The Inflation Reduction Act (IRA) is bringing landmark policy changes to the healthcare industry, raising important questions about drug pricing, plan economics, and negotiation. In this series, the IRA Question of the Week, Avalere answers the pressing questions shaping healthcare stakeholders’ strategic decision-making as the IRA is implemented. In this installment, Avalere experts consider the impacts of the IRA on drug coverage for the rough…

We Need Congress to Get Serious About Lowering Drug Costs

This article accompanies a primer on pharmacy benefit managers from June 2025. You can read more here. There is widespread, bipartisan belief across the country that prescription drug costs are too high. So, why won’t Congress get serious about lowering costs and reforming one of the most influential players in the drug supply chain, pharmacy benefit managers (PBMs)?  PBMs, the middlemen of the drug supply chain, were originally created to strea…